Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses

Barbara K. Burton*, Chani Wiesman, Andrea Paras, Katherine Kim, Rachel Katz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

The transition to home infusion therapy is described in 11 patients with mucopolysaccharide (MPS) disorders initially treated with enzyme replacement therapy (ERT) in an out-patient infusion center. Home therapy was well tolerated with no infusion-related reactions (IRR) occurring in 671 patient-weeks of treatment. In addition, compliance with the weekly treatment regimen was improved in patients on home therapy.

Original languageEnglish (US)
Pages (from-to)234-236
Number of pages3
JournalMolecular Genetics and Metabolism
Volume97
Issue number3
DOIs
StatePublished - Jul 2009

Keywords

  • Enzyme replacement therapy
  • Home infusion
  • Hunter syndrome
  • Mucopolysaccharidoses

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Fingerprint Dive into the research topics of 'Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses'. Together they form a unique fingerprint.

Cite this